Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges

Transthyretin amyloid cardiomyopathy (ATTR-CM) is potentially a fatal disease characterized by abnormal buildup of amyloid fibrils primarily in the heart causing progressive heart failure. It is categorized into two subtypes-hereditary ATTR and wild type ATTR. Previously, no treatment is available,...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sweety Sharma, Bhawna Sharma
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2021-01-01
Colección:	Journal of Public Health and Primary Care
Materias:	amyloid amyloidosis cardiomyopathy transthyretin transthyretin amyloid cardiomyopathy
Acceso en línea:	http://www.jphpc.org/article.asp?issn=2772-3666;year=2021;volume=2;issue=2;spage=32;epage=37;aulast=Sharma
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!